I think this could be a $1 billion-a-year-drug and is the kind of product Pfizer needs.

Now, she needs to be more external,

I understand that his name starts with D and that he wears No. 3 but he needs to get a new nickname.

We have a team that needs to dictate tempo. We?re not big, we?re not quick, we?re not going to overpower you with talent. What we have to do is do two or three fundamental things well.

[BXXP] looks like a good approach to some real needs, but it is very early in the process.

We're not ruling things out. We're looking at what needs to be done to address problems.